Enhanced osteopontin splicing regulated by RUNX2 is HDAC-dependent and induces invasive phenotypes in NSCLC cells
Published 2019 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Enhanced osteopontin splicing regulated by RUNX2 is HDAC-dependent and induces invasive phenotypes in NSCLC cells
Authors
Keywords
-
Journal
Cancer Cell International
Volume 19, Issue 1, Pages -
Publisher
Springer Science and Business Media LLC
Online
2019-11-21
DOI
10.1186/s12935-019-1033-5
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- The cancer-related transcription factor RUNX2 modulates expression and secretion of the matricellular protein osteopontin in osteosarcoma cells to promote adhesion to endothelial pulmonary cells and lung metastasis
- (2019) Francisco Villanueva et al. JOURNAL OF CELLULAR PHYSIOLOGY
- CREB1 induced lncRNA HAS2-AS1 promotes epithelial ovarian cancer proliferation and invasion via the miR-466/RUNX2 axis
- (2019) Lingling Tong et al. BIOMEDICINE & PHARMACOTHERAPY
- Prognostic value of fibrosis-related markers in dilated cardiomyopathy: A link between osteopontin and cardiovascular events
- (2018) Paweł Rubiś et al. Advances in Medical Sciences
- Impact of RUNX2 on drug-resistant human pancreatic cancer cells with p53 mutations
- (2018) Toshinori Ozaki et al. BMC CANCER
- Cancer screening in the United States, 2018: A review of current American Cancer Society guidelines and current issues in cancer screening
- (2018) Robert A. Smith et al. CA-A CANCER JOURNAL FOR CLINICIANS
- An alternative splicing switch in FLNB promotes the mesenchymal cell state in human breast cancer
- (2018) Ji Li et al. eLife
- Histone deacetylase 1 activates PU.1 gene transcription through regulating TAF9 deacetylation and transcription factor IID assembly
- (2017) Wei Jian et al. FASEB JOURNAL
- Progression and metastasis of lung cancer
- (2016) Helmut H. Popper CANCER AND METASTASIS REVIEWS
- Regulation of Runx2 by Histone Deacetylases in Bone
- (2016) Mohanakrishnan Vishal et al. CURRENT PROTEIN & PEPTIDE SCIENCE
- Osteopontin—A Master Regulator of Epithelial-Mesenchymal Transition
- (2016) Anai Kothari et al. Journal of Clinical Medicine
- RUNX2 and Osteosarcoma
- (2015) Na Li et al. Anti-Cancer Agents in Medicinal Chemistry
- Role of RUNX2 in Breast Carcinogenesis
- (2015) Daniel Wysokinski et al. INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES
- Osteopontin (OPN) Isoforms, Diabetes, Obesity, and Cancer; What Is One Got to Do with the Other? A New Role for OPN
- (2015) Konrad Sarosiek et al. JOURNAL OF GASTROINTESTINAL SURGERY
- Repression of TIF1γ by SOX2 promotes TGF-β-induced epithelial–mesenchymal transition in non-small-cell lung cancer
- (2015) L Wang et al. ONCOGENE
- Role of Runx2 phosphorylation in prostate cancer and association with metastatic disease
- (2015) C Ge et al. ONCOGENE
- Emerging Functions of SRSF1, Splicing Factor and Oncoprotein, in RNA Metabolism and Cancer
- (2014) S. Das et al. MOLECULAR CANCER RESEARCH
- Pro-apoptotic Bim suppresses breast tumor cell metastasis and is a target gene of SNAI2
- (2014) D Merino et al. ONCOGENE
- Lung cancer-derived Dickkopf1 is associated with bone metastasis and the mechanism involves the inhibition of osteoblast differentiation
- (2013) Tianqing Chu et al. BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS
- Prognostic values of osteopontin-c, E-cadherin and β-catenin in breast cancer
- (2013) Hui Pang et al. Cancer Epidemiology
- Identification of Alternative Splicing Events Regulated by the Oncogenic Factor SRSF1 in Lung Cancer
- (2013) F. J. de Miguel et al. CANCER RESEARCH
- Exo70 Isoform Switching upon Epithelial-Mesenchymal Transition Mediates Cancer Cell Invasion
- (2013) Hezhe Lu et al. DEVELOPMENTAL CELL
- A novel method that improves sensitivity of protein detection in PAGE and Western blot
- (2013) Ainara Vallejo-Illarramendi et al. ELECTROPHORESIS
- RNA-dependent dynamic histone acetylation regulates MCL1 alternative splicing
- (2013) Dilshad H. Khan et al. NUCLEIC ACIDS RESEARCH
- Human osteopontin splicing isoforms: Known roles, potential clinical applications and activated signaling pathways
- (2012) E.R. Gimba et al. CANCER LETTERS
- Oncogenic Splicing Factor SRSF1 Is a Critical Transcriptional Target of MYC
- (2012) Shipra Das et al. Cell Reports
- Osteopontin, an oxidant stress sensitive cytokine, up-regulates collagen-I via integrin αVβ3 engagement and PI3K/pAkt/NFκB signaling
- (2011) Raquel Urtasun et al. HEPATOLOGY
- CD44 splice isoform switching in human and mouse epithelium is essential for epithelial-mesenchymal transition and breast cancer progression
- (2011) Rhonda L. Brown et al. JOURNAL OF CLINICAL INVESTIGATION
- An EMT–Driven Alternative Splicing Program Occurs in Human Breast Cancer and Modulates Cellular Phenotype
- (2011) Irina M. Shapiro et al. PLoS Genetics
- Functional Heterogeneity of Osteopontin Isoforms in Non-small Cell Lung Cancer
- (2010) Chandra M.V. Goparaju et al. Journal of Thoracic Oncology
- ESRP1 and ESRP2 Are Epithelial Cell-Type-Specific Regulators of FGFR2 Splicing
- (2009) Claude C. Warzecha et al. MOLECULAR CELL
Publish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn MoreBecome a Peeref-certified reviewer
The Peeref Institute provides free reviewer training that teaches the core competencies of the academic peer review process.
Get Started